High-Dose Vitamin D-Mediated Hypercalcemia as a Potential Risk Factor in Central Nervous System Demyelinating Disease
The exact cause of multiple sclerosis (MS) is unknown; however, it is considered to be an inflammatory disease of the central nervous system (CNS) triggered by a combination of both environmental and genetic factors. Vitamin D deficiency is also discussed as a possible disease-promoting factor in MS...
Main Authors: | Darius Häusler, Sebastian Torke, Martin S. Weber |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-02-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2020.00301/full |
Similar Items
-
Vitamin D Supplementation in Central Nervous System Demyelinating Disease—Enough Is Enough
by: Darius Häusler, et al.
Published: (2019-01-01) -
Editorial: Multiple Sclerosis – From Bench to Bedside: Currents Insights Into Pathophysiological Concepts and Their Potential Impact on Patients
by: Paulus S. Rommer, et al.
Published: (2020-02-01) -
Aquaporin-4 Immuneglobulin G testing in 36 consecutive Jamaican patients with inflammatory central nervous system demyelinating disease
by: Sherri Sandy, et al.
Published: (2014-08-01) -
Absence of perforin expression confers axonal protection despite demyelination
by: Charles L. Howe, et al.
Published: (2007-02-01) -
Expanding Role of T Cells in Human Autoimmune Diseases of the Central Nervous System
by: Deepti Pilli, et al.
Published: (2017-06-01)